FundedIQ
Biotechnology

Pear Bio: Funding, Investors & Team (Oct 2026)

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

pearbio.com LinkedIn London, United Kingdom 11-50 employees
Total raised
$19.9M
Rounds
4
Latest
Series A
May 2023

Pear Bio has raised $19.9M across 4 funding rounds on record, the most recent a Series A of $14.0M announced in May 2023.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Pear Bio Company Profile and Key Stats

Total funding raised
$19.9M
across 4 rounds on record
Funding rounds on record
4
Latest funding round
Series A
$14.0M in May 2023
Employees
11-50
reported band
Headquarters
London, United Kingdom

Latest funding round on record: May 2023.

Pear Bio Funding Rounds

Date
Round
Amount
Series A
$14.0M
Grant
$100k
Undisclosed round
$4.6M
Undisclosed round
$1.2M

Pear Bio raised $1.2M in an undisclosed round announced in Dec 2020.

11 months later, an undisclosed round of $4.6M was announced in Nov 2021.

4 months later, a Grant of $100k was announced in Mar 2022.

1.2 years later, a Series A of $14.0M was announced in May 2023.

Pear Bio Founders and Leadership Team

Name
Role
Contact
Duleek Ranatunga
CEO
Locked

Contact details for the Pear Bio team: 1 of 1 has an email address on file.

Start 14-day free trial →

Pear Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
5,368
$4.1M
8,591
$15M

Pear Bio's latest round of $14.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Pear Bio in Biotechnology and London

Companies Similar to Pear Bio

Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…

Series C $40.4M

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…

Series C $310M

HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…

Series A $8.0M

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

Pear Bio Funding FAQs

What does Pear Bio do?

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

How much funding has Pear Bio raised?

Pear Bio has raised $19.9M across 4 rounds on record. The most recent is a Series A of $14.0M announced in May 2023.

When did Pear Bio last raise funding?

Pear Bio's most recent funding round on record is a Series A of $14.0M, announced in May 2023.

Who is the CEO of Pear Bio?

Duleek Ranatunga is listed as CEO at Pear Bio.

Where is Pear Bio headquartered?

Pear Bio is based in London, England, United Kingdom.

How many employees does Pear Bio have?

Pear Bio is in the 11-50 employee band.

How does Pear Bio's funding compare to other Biotechnology startups?

Pear Bio's latest round of $14.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Pear Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pear Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.